Evidence-Based Recommendations for Local Antimicrobial Strategies and Dead Space Management in Fracture-Related Infection

Willem-Jan Metsemakers, Austin T Fragomen, T Fintan Moriarty, Mario Morgenstern, Kenneth A Egol, Charalampos Zalavras, William T Obremskey, Michael Raschke, Martin A McNally, Fracture-Related Infection (FRI) consensus group, Willem-Jan Metsemakers, Austin T Fragomen, T Fintan Moriarty, Mario Morgenstern, Kenneth A Egol, Charalampos Zalavras, William T Obremskey, Michael Raschke, Martin A McNally, Fracture-Related Infection (FRI) consensus group

Abstract

Fracture-related infection (FRI) remains a challenging complication that imposes a heavy burden on orthopaedic trauma patients. The surgical management eradicates the local infectious focus and if necessary facilitates bone healing. Treatment success is associated with debridement of all dead and poorly vascularized tissue. However, debridement is often associated with the formation of a dead space, which provides an ideal environment for bacteria and is a potential site for recurrent infection. Dead space management is therefore of critical importance. For this reason, the use of locally delivered antimicrobials has gained attention not only for local antimicrobial activity but also for dead space management. Local antimicrobial therapy has been widely studied in periprosthetic joint infection, without addressing the specific problems of FRI. Furthermore, the literature presents a wide array of methods and guidelines with respect to the use of local antimicrobials. The present review describes the scientific evidence related to dead space management with a focus on the currently available local antimicrobial strategies in the management of FRI. LEVEL OF EVIDENCE:: Therapeutic Level V. See Instructions for Authors for a complete description of levels of evidence.

Conflict of interest statement

The authors report no conflict of interest.

Figures

FIGURE 1.
FIGURE 1.
A, Polymethyl methacrylate (PMMA)–coated humeral nail. The nail was custom molded (handmade) in the operating room using PMMA and a combination of antibiotics. B, PMMA spacer for application in the IM canal of the tibia. The application of PMMA on a rod was achieved using a hand rolling technique.

References

    1. Metsemakers WJ, Kuehl R, Moriarty TF, et al. Infection after fracture fixation: current surgical and microbiological concepts. Injury. 2018;49:511–522.
    1. McNally MA. Infection after fracture. In: Kates S, Borens O, eds. Principles of Orthopedic Infection. New York, NY: Thieme Verlag; 2016:139–165.
    1. Patzakis MJ, Mazur K, Wilkins J, et al. Septopal beads and autogenous bone grafting for bone defects in patients with chronic osteomyelitis. Clin Orthop Relat Res. 1993;295:112–118.
    1. Calhoun JH, Henry SL, Anger DM, et al. The treatment of infected nonunions with gentamicin-polymethylmethacrylate antibiotic beads. Clin Orthop Relat Res. 1993;295:23–27.
    1. Blaha JD, Calhoun JH, Nelson CL, et al. Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis. Clin Orthop Relat Res. 1993;295:8–12.
    1. Turner TM, Urban RM, Hall DJ, et al. Local and systemic levels of tobramycin delivered from calcium sulfate bone graft substitute pellets. Clin Orthop Relat Res. 2005;437:97–104.
    1. Rand BC, Penn-Barwell JG, Wenke JC. Combined local and systemic antibiotic delivery improves eradication of wound contamination: an animal experimental model of contaminated fracture. Bone Joint J. 2015;97-B:1423–1427.
    1. Hake ME, Young H, Hak DJ, et al. Local antibiotic therapy strategies in orthopaedic trauma: practical tips and tricks and review of the literature. Injury. 2015;46:1447–1456.
    1. Cooper C, Horner C, Barlow G, et al. A survey of practice and opinions on the use of topical antibiotics to prevent surgical site infection: more confusion than consensus. J Antimicrob Chemother. 2018;73:1978–1983.
    1. Dudareva M, Barrett L, Figtree M, et al. Sonication versus tissue sampling for diagnosis of prosthetic joint and other orthopedic device-related infections. J Clin Microbiol. 2018;56.
    1. Bhandari M, Bhandari M, Jeray KJ, et al. A trial of wound irrigation in the initial management of open fracture wounds. N Engl J Med. 2015;373:2629–2641.
    1. Anglen JO. Wound irrigation in musculoskeletal injury. J Am Acad Orthop Surg. 2001;9:219–226.
    1. Draeger RW, Dahners LE. Traumatic wound debridement: a comparison of irrigation methods. J Orthop Trauma. 2006;20:83–88.
    1. Yun HC, Murray CK, Nelson KJ, et al. Infection after orthopaedic trauma: prevention and treatment. J Orthop Trauma. 2016;30(suppl 3):S21–S26.
    1. Penn-Barwell JG, Murray CK, Wenke JC. Comparison of the antimicrobial effect of chlorhexidine and saline for irrigating a contaminated open fracture model. J Orthop Trauma. 2012;26:728–732.
    1. Ferguson J, Diefenbeck M, McNally M. Ceramic biocomposites as biodegradable antibiotic carriers in the treatment of bone infections. J Bone Joint Infect. 2017;2:38–51.
    1. Sheehy SH, Atkins BA, Bejon P, et al. The microbiology of chronic osteomyelitis: prevalence of resistance to common empirical anti-microbial regimens. J Infect. 2010;60:338–343.
    1. Olesen UK, Juul R, Bonde CT, et al. A review of forty five open tibial fractures covered with free flaps. Analysis of complications, microbiology and prognostic factors. Int Orthop. 2015;39:1159–1166.
    1. Samara E, Moriarty TF, Decosterd LA, et al. Antibiotic stability over six weeks in aqueous solution at body temperature with and without heat treatment that mimics the curing of bone cement. Bone Joint Res. 2017;6:296–306.
    1. Springer BD, Lee GC, Osmon D, et al. Systemic safety of high-dose antibiotic-loaded cement spacers after resection of an infected total knee arthroplasty. Clin Orthop Relat Res. 2004;427:47–51.
    1. van Raaij TM, Visser LE, Vulto AG, et al. Acute renal failure after local gentamicin treatment in an infected total knee arthroplasty. J Arthroplasty. 2002;17:948–950.
    1. Rathbone CR, Cross JD, Brown KV, et al. Effect of various concentrations of antibiotics on osteogenic cell viability and activity. J Orthop Res. 2011;29:1070–1074.
    1. Antoci V, Jr, Adams CS, Hickok NJ, et al. Antibiotics for local delivery systems cause skeletal cell toxicity in vitro. Clin Orthop Relat Res. 2007;462:200–206.
    1. McLaren AC. Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin Orthop Relat Res. 2004;427:101–106.
    1. Ter Boo GJ, Schmid T, Zderic I, et al. Local application of a gentamicin-loaded thermo-responsive hydrogel allows for fracture healing upon clearance of a high Staphylococcus aureus load in a rabbit model. Eur Cell Mater. 2018;35:151–164.
    1. Fassbender M, Minkwitz S, Kronbach Z, et al. Local gentamicin application does not interfere with bone healing in a rat model. Bone. 2013;55:298–304.
    1. Chu S, Chen N, Dang ABC, et al. The effects of topical vancomycin on mesenchymal stem cells: more may not Be better. Int J Spine Surg. 2017;11:12.
    1. Naal FD, Salzmann GM, von Knoch F, et al. The effects of clindamycin on human osteoblasts in vitro. Arch Orthop Trauma Surg. 2008;128:317–323.
    1. Holtom PD, Pavkovic SA, Bravos PD, et al. Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro. J Orthop Res. 2000;18:721–727.
    1. Huddleston PM, Steckelberg JM, Hanssen AD, et al. Ciprofloxacin inhibition of experimental fracture healing. J Bone Joint Surg Am. 2000;82:161–173.
    1. Kallala R, Graham SM, Nikkhah D, et al. In vitro and in vivo effects of antibiotics on bone cell metabolism and fracture healing. Expert Opin Drug Saf. 2012;11:15–32.
    1. Jaeblon T. Polymethylmethacrylate: properties and contemporary uses in orthopaedics. J Am Acad Orthop Surg. 2010;18:297–305.
    1. Holtom PD, Patzakis MJ. Newer methods of antimicrobial delivery for bone and joint infections. Instr Course Lect. 2003;52:745–749.
    1. Morimoto S, Futani H, Ogura H, et al. Successful reimplantation of total femoral prosthesis after deep infection. J Arthroplasty. 2003;18:216–220.
    1. Qiang Z, Jun PZ, Jie XJ, et al. Use of antibiotic cement rod to treat intramedullary infection after nailing: preliminary study in 19 patients. Arch Orthop Trauma Surg. 2007;127:945–951.
    1. Sancineto CF, Barla JD. Treatment of long bone osteomyelitis with a mechanically stable intramedullar antibiotic dispenser: nineteen consecutive cases with a minimum of 12 months follow-up. J Trauma. 2008;65:1416–1420.
    1. Madanagopal SG, Seligson D, Roberts CS. The antibiotic cement nail for infection after tibial nailing. Orthopedics. 2004;27:709–712.
    1. Jung J, Schmid NV, Kelm J, et al. Complications after spacer implantation in the treatment of hip joint infections. Int J Med Sci. 2009;6:265–273.
    1. Kanakaris NK, Morell D, Gudipati S, et al. Reaming Irrigator Aspirator system: early experience of its multipurpose use. Injury. 2011;42(suppl 4):S28–S34.
    1. Bhadra AK, Roberts CS. Indications for antibiotic cement nails. J Orthop Trauma. 2009;23:S26–S30.
    1. Zalavras CG, Patzakis MJ, Holtom P. Local antibiotic therapy in the treatment of open fractures and osteomyelitis. Clin Orthop Relat Res. 2004;427:86–93.
    1. Mauffrey C, Chaus GW, Butler N, et al. MR-compatible antibiotic interlocked nail fabrication for the management of long bone infections: first case report of a new technique. Patient Saf Surg. 2014;8:14.
    1. Kühn KD, Renz N, Trampuz A. Lokale antibiotikatherapie. Unfallchirurg. 2017;120:561–572.
    1. Wahl P, Guidi M, Benninger E, et al. The levels of vancomycin in the blood and the wound after the local treatment of bone and soft-tissue infection with antibiotic-loaded calcium sulphate as carrier material. Bone Joint J. 2017;99-B:1537–1544.
    1. Bibbo C, Patel DV. The effect of demineralized bone matrix-calcium sulfate with vancomycin on calcaneal fracture healing and infection rates: a prospective study. Foot Ankle Int. 2006;27:487–493.
    1. Badie AA, Arafa MS. One-stage surgery for adult chronic osteomyelitis: concomitant use of antibiotic-loaded calcium sulphate and bone marrow aspirate. Int Orthop. 2019;43:1061–1070.
    1. Lum ZC, Pereira GC. Local bio-absorbable antibiotic delivery in calcium sulfate beads in hip and knee arthroplasty. J Orthop. 2018;15:676–678.
    1. Bakhsheshian J, Dahdaleh NS, Lam SK, et al. The use of vancomycin powder in modern spine surgery: systematic review and meta-analysis of the clinical evidence. World Neurosurg. 2015;83:816–823.
    1. Ghobrial GM, Thakkar V, Andrews E, et al. Intraoperative vancomycin use in spinal surgery: single institution experience and microbial trends. Spine. 2014;39:550–555.
    1. Yao R, Tan T, Tee JW, et al. Prophylaxis of surgical site infection in adult spine surgery: a systematic review. J Clin Neurosci. 2018;52:5–25.
    1. Cancienne JM, Burrus MT, Weiss DB, et al. Applications of local antibiotics in orthopedic trauma. Orthop Clin North Am. 2015;46:495–510.
    1. Lawing CR, Lin FC, Dahners LE. Local injection of aminoglycosides for prophylaxis Against infection in open fractures. J Bone Joint Surg Am. 2015;97:1844–1851.
    1. Owen MT, Keener EM, Hyde ZB, et al. Intraoperative topical antibiotics for infection prophylaxis in pelvic and acetabular surgery. J Orthop Trauma. 2017;31:589–594.
    1. Takeuchi M, Wakao N, Kamiya M, et al. A double-blind randomized controlled trial of the local application of vancomycin versus ampicillin powder into the operative field for thoracic and/or lumbar fusions. J Neurosurg Spine. 2018;29:553–559.
    1. Curtis JM, Sternhagen V, Batts D. Acute renal failure after placement of tobramycin-impregnated bone cement in an infected total knee arthroplasty. Pharmacotherapy. 2005;25:876–880.
    1. Dovas S, Liakopoulos V, Papatheodorou L, et al. Acute renal failure after antibiotic-impregnated bone cement treatment of an infected total knee arthroplasty. Clin Nephrol. 2008;69:207–212.
    1. Patrick BN, Rivey MP, Allington DR. Acute renal failure associated with vancomycin- and tobramycin-laden cement in total hip arthroplasty. Ann Pharmacother. 2006;40:2037–2042.
    1. Clyburn TA, Cui Q. Antibiotic Laden Cement: Current State of the Art. AAOS Now: 2007;1:17–18.
    1. McNally MA, Ferguson JY, Lau AC, et al. Single-stage treatment of chronic osteomyelitis with a new absorbable, gentamicin-loaded, calcium sulphate/hydroxyapatite biocomposite: a prospective series of 100 cases. Bone Joint J. 2016;98-B:1289–1296.
    1. Fleischman AN, Austin MS. Local intra-wound administration of powdered antibiotics in orthopaedic surgery. J Bone Joint Infect. 2017;2:23–28.
    1. Tubaki VR, Rajasekaran S, Shetty AP. Effects of using intravenous antibiotic only versus local intrawound vancomycin antibiotic powder application in addition to intravenous antibiotics on postoperative infection in spine surgery in 907 patients. Spine. 2013;38:2149–2155.
    1. Adogwa O, Elsamadicy AA, Sergesketter A, et al. Prophylactic use of intraoperative vancomycin powder and postoperative infection: an analysis of microbiological patterns in 1200 consecutive surgical cases. J Neurosurg Spine. 2017;27:328–334.
    1. Firoozabadi R, Miranda S, Tornetta P., III Technique for placement of peri-implant antibiotics using antibiotic putty. J Orthop Trauma. 2017;31:e442–e445.
    1. Shiels SM, Tennent DJ, Wenke JC. Topical Rifampin Powder for Orthopaedic Trauma Part I: rifampin powder reduces recalcitrant infection in a delayed treatment musculoskeletal trauma model. J Orthop Res. 2018;36:3136–3141.
    1. Tennent DJ, Shiels SM, Sanchez CJ, Jr, et al. Time-dependent effectiveness of locally applied vancomycin powder in a contaminated traumatic orthopaedic wound model. J Orthop Trauma. 2016;30:531–537.
    1. Caroom C, Moore D, Mudaliar N, et al. Intrawound vancomycin powder reduces bacterial load in contaminated open fracture model. J Orthop Trauma. 2018;32:538–541.
    1. O'Toole RV, Joshi M, Carlini AR, et al. Local antibiotic therapy to reduce infection after operative treatment of fractures at high risk of infection: a multicenter, randomized, controlled trial (VANCO study). J Orthop Trauma. 2017;31(suppl 1):S18–S24.
    1. Cavanaugh DL, Berry J, Yarboro SR, et al. Better prophylaxis against surgical site infection with local as well as systemic antibiotics. An in vivo study. J Bone Joint Surg Am. 2009;91:1907–1912.
    1. Egol KA, Nauth A, Lee M, et al. Bone grafting: sourcing, timing, strategies, and alternatives. J Orthop Trauma. 2015;29(suppl 12):S10–S14.
    1. Dawson J, Kiner D, Gardner W, II, et al. The reamer-irrigator-aspirator as a device for harvesting bone graft compared with iliac crest bone graft: union rates and complications. J Orthop Trauma. 2014;28:584–590.
    1. Glotzbecker MP, Riedel MD, Vitale MG, et al. What's the evidence? Systematic literature review of risk factors and preventive strategies for surgical site infection following pediatric spine surgery. J Pediatr Orthop. 2013;33:479–487.
    1. Morelli I, Drago L, George DA, et al. Masquelet technique: myth or reality? A systematic review and meta-analysis. Injury. 2016;47(suppl 6):S68–S76.
    1. Wang X, Luo F, Huang K, et al. Induced membrane technique for the treatment of bone defects due to post-traumatic osteomyelitis. Bone Joint Res. 2016;5:101–105.
    1. Scholz AO, Gehrmann S, Glombitza M, et al. Reconstruction of septic diaphyseal bone defects with the induced membrane technique. Injury. 2015;46(suppl 4):S121–S124.
    1. Moghaddam A, Zietzschmann S, Bruckner T, et al. Treatment of atrophic tibia non-unions according to 'diamond concept': results of one- and two-step treatment. Injury. 2015;46(suppl 4):S39–S50.
    1. Wong TM, Lau TW, Li X, et al. Masquelet technique for treatment of posttraumatic bone defects. ScientificWorldJournal. 2014;2014:710302.
    1. Shiels SM, Raut VP, Patterson PB, et al. Antibiotic-loaded bone graft for reduction of surgical site infection in spinal fusion. Spine J. 2017;17:1917–1925.
    1. Haimoto S, Schär RT, Nishimura Y, et al. Reduction in surgical site infection with suprafascial intrawound application of vancomycin powder in instrumented posterior spinal fusion: a retrospective case-control study. J Neurosurg Spine. 2018;29:193–198.
    1. Karargyris O, Polyzois VD, Karabinas P, et al. Papineau debridement, Ilizarov bone transport, and negative-pressure wound closure for septic bone defects of the tibia. Eur J Orthop Surg Traumatol. 2014;24:1013–1017.
    1. Papineau LJ. Excision-graft with deliberately delayed closing in chronic osteomyelitis [in French]. Nouv Presse Med. 1973;2:2753–2755.
    1. Seebach E, Holschbach J, Buchta N, et al. Mesenchymal stromal cell implantation for stimulation of long bone healing aggravates Staphylococcus aureus induced osteomyelitis. Acta Biomater. 2015;21:165–177.
    1. Patzakis MJ, Zalavras CG. Chronic posttraumatic osteomyelitis and infected nonunion of the tibia: current management concepts. J Am Acad Orthop Surg. 2005;13:417–427.
    1. Lindsey RW, Probe R, Miclau T, et al. The effects of antibiotic-impregnated autogeneic cancellous bone graft on bone healing. Clin Orthop Relat Res. 1993;291:303–312.
    1. Chan YS, Ueng SW, Wang CJ, et al. Antibiotic-impregnated autogenic cancellous bone grafting is an effective and safe method for the management of small infected tibial defects: a comparison study. J Trauma. 2000;48:246–255.
    1. Chen CE, Ko JY, Pan CC. Results of vancomycin-impregnated cancellous bone grafting for infected tibial nonunion. Arch Orthop Trauma Surg. 2005;125:369–375.
    1. Atique FB, Khalil MM. The bacterial contamination of allogeneic bone and emergence of multidrug-resistant bacteria in tissue bank. Biomed Res Int. 2014;2014:430581.
    1. Aponte-Tinao LA, Ayerza MA, Muscolo DL, et al. What are the risk factors and management options for infection after reconstruction with massive bone allografts? Clin Orthop Relat Res. 2016;474:669–673.
    1. Winkler H, Haiden P. Allograft bone as antibiotic carrier. J Bone Joint Infect. 2017;2:52–62.
    1. Dastgheyb SS, Toorkey CB, Shapiro IM, et al. Porphyrin-adsorbed allograft bone: a photoactive, antibiofilm surface. Clin Orthop Relat Res. 2015;473:2865–2873.
    1. Barckman J, Baas J, Sorensen M, et al. Does tobramycin impregnation of allograft bone affect implant fixation?—an experimental study in 12 dogs. J Biomed Mater Res B Appl Biomater. 2014;102:173–180.
    1. Coraca-Huber DC, Ammann CG, Nogler M, et al. Lyophilized allogeneic bone tissue as an antibiotic carrier. Cell Tissue Bank. 2016;17:629–642.
    1. Anagnostakos K, Koch K. Pharmacokinetic properties and systemic safety of vancomycin-impregnated cancellous bone grafts in the treatment of spondylodiscitis. Biomed Res Int. 2013;2013:358217.
    1. Ketonis C, Barr S, Shapiro IM, et al. Antibacterial activity of bone allografts: comparison of a new vancomycin-tethered allograft with allograft loaded with adsorbed vancomycin. Bone. 2011;48:631–638.
    1. Almodóvar J, Mower J, Banerjee A, et al. Chitosan-heparin polyelectrolyte multilayers on cortical bone: periosteum-mimetic, cytophilic, antibacterial coatings. Biotechnol Bioeng. 2013;110:609–618.
    1. Winkler H, Kaudela K, Stoiber A, et al. Bone grafts impregnated with antibiotics as a tool for treating infected implants in orthopedic surgery - one stage revision results. Cell Tissue Bank. 2006;7:319–323.
    1. Barger J, Fragomen AT, Rozbruch SR. Antibiotic-coated interlocking intramedullary nail for the treatment of long-bone osteomyelitis. JBJS Rev. 2017;5:e5.
    1. Thonse R, Conway JD. Antibiotic cement-coated nails for the treatment of infected nonunions and segmental bone defects. J Bone Joint Surg Am. 2008;90(suppl 4):163–174.
    1. Penner MJ, Duncan CP, Masri BA. The in vitro elution characteristics of antibiotic-loaded CMW and Palacos-R bone cements. J Arthroplasty. 1999;14:209–214.
    1. Penalba Arias P, Furustrand Tafin U, Betrisey B, et al. Activity of bone cement loaded with daptomycin alone or in combination with gentamicin or PEG600 against Staphylococcus epidermidis biofilms. Injury. 2015;46:249–253.
    1. Kuechle DK, Landon GC, Musher DM, et al. Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement. Clin Orthop Relat Res. 1991;264:302–308.
    1. Grimsrud C, Raven R, Fothergill AW, et al. The in vitro elution characteristics of antifungal-loaded PMMA bone cement and calcium sulfate bone substitute. Orthopedics. 2011;34:e378–e381.
    1. Walenkamp GH, Kleijn LL, de Leeuw M. Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1-12 years. Acta Orthop Scand. 1998;69:518–522.
    1. Morgenstern M, Vallejo A, McNally MA, et al. The effect of local antibiotic prophylaxis when treating open limb fractures: a systematic review and meta-analysis. Bone Joint Res. 2018;7:447–456.
    1. Decoster TA, Bozorgnia S. Antibiotic beads. J Am Acad Orthop Surg. 2008;16:674–678.
    1. Wasko MK, Kaminski R. Custom-made antibiotic cement nails in orthopaedic trauma: review of outcomes, new approaches, and perspectives. Biomed Res Int. 2015;2015:387186.
    1. Kanakaris N, Gudipati S, Tosounidis T, et al. The treatment of intramedullary osteomyelitis of the femur and tibia using the Reamer-Irrigator-Aspirator system and antibiotic cement rods. Bone Joint J. 2014;96-B:783–788.
    1. Yu X, Wu H, Li J, et al. Antibiotic cement-coated locking plate as a temporary internal fixator for femoral osteomyelitis defects. Int Orthop. 2017;41:1851–1857.
    1. Schmidmaier G, Kerstan M, Schwabe P, et al. Clinical experiences in the use of a gentamicin-coated titanium nail in tibia fractures. Injury. 2017;48:2235–2241.
    1. Reilly RM, Robertson T, O'Toole RV, et al. Are antibiotic nails effective in the treatment of infected tibial fractures? Injury. 2016;47:2809–2815.
    1. Wasko MK, Borens O. Antibiotic cement nail for the treatment of posttraumatic intramedullary infections of the tibia: midterm results in 10 cases. Injury. 2013;44:1057–1060.
    1. Conway J, Mansour J, Kotze K, et al. Antibiotic cement-coated rods: an effective treatment for infected long bones and prosthetic joint nonunions. Bone Joint J. 2014;96-B:1349–1354.
    1. Pawar A, Dikmen G, Fragomen A, et al. Antibiotic-coated nail for fusion of infected charcot ankles. Foot Ankle Int. 2013;34:80–84.
    1. Greene N, Holtom PD, Warren CA, et al. In vitro elution of tobramycin and vancomycin polymethylmethacrylate beads and spacers from Simplex and Palacos. Am J Orthop. 1998;27:201–205.
    1. Chang YH, Tai CL, Hsu HY, et al. Liquid antibiotics in bone cement: an effective way to improve the efficiency of antibiotic release in antibiotic loaded bone cement. Bone Joint Res. 2014;3:246–251.
    1. Barth RE, Vogely HC, Hoepelman AI, et al. “To bead or not to bead?” Treatment of osteomyelitis and prosthetic joint-associated infections with gentamicin bead chains. Int J Antimicrob Agents. 2011;38:371–375.
    1. van de Belt H, Neut D, Uges DR, et al. Surface roughness, porosity and wettability of gentamicin-loaded bone cements and their antibiotic release. Biomaterials. 2000;21:1981–1987.
    1. Neut D, van de Belt H, Stokroos I, et al. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother. 2001;47:885–891.
    1. Webb ND, McCanless JD, Courtney HS, et al. Daptomycin eluted from calcium sulfate appears effective against Staphylococcus. Clin Orthop Relat Res. 2008;466:1383–1387.
    1. Howlin RP, Brayford MJ, Webb JS, et al. Antibiotic-loaded synthetic calcium sulfate beads for prevention of bacterial colonization and biofilm formation in periprosthetic infections. Antimicrob Agents Chemother. 2015;59:111–120.
    1. McKee MD, Li-Bland EA, Wild LM, et al. A prospective, randomized clinical trial comparing an antibiotic-impregnated bioabsorbable bone substitute with standard antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis and infected nonunion. J Orthop Trauma. 2010;24:483–490.
    1. Gitelis S, Brebach GT. The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant. J Orthop Surg (Hong Kong). 2002;10:53–60.
    1. Chang W, Colangeli M, Colangeli S, et al. Adult osteomyelitis: debridement versus debridement plus Osteoset T pellets. Acta Orthop Belg. 2007;73:238–243.
    1. Humm G, Noor S, Bridgeman P, et al. Adjuvant treatment of chronic osteomyelitis of the tibia following exogenous trauma using OSTEOSET((R))-T: a review of 21 patients in a regional trauma centre. Strateg Trauma Limb Reconstr. 2014;9:157–161.
    1. Ferguson JY, Dudareva M, Riley ND, et al. The use of a biodegradable antibiotic-loaded calcium sulphate carrier containing tobramycin for the treatment of chronic osteomyelitis: a series of 195 cases. Bone Joint J. 2014;96-B:829–836.
    1. McNally M, Ferguson J, Kendall J, et al. A comparative study of three bioabsorbable antibiotic carriers in chronic osteomyelitis: 313 patients with minimum one-year follow-up. Bone Joint J Orthop Proc. 2015;97-B.
    1. McNally M, Ferguson J, Mifsud M, et al. Internal fixation and local antibiotics for infected nonunions: technique and outcome at over one year. Bone Joint J Orthop Proc. 2018;100-B(supp 8).
    1. Rahaman MN, Day DE, Bal BS, et al. Bioactive glass in tissue engineering. Acta Biomater. 2011;7:2355–2373.
    1. Kaur G, Pandey OP, Singh K, et al. A review of bioactive glasses: their structure, properties, fabrication and apatite formation. J Biomed Mater Res A. 2014;102:254–274.
    1. Lindfors N, Geurts J, Drago L, et al. Antibacterial bioactive glass, S53P4, for chronic bone infections—a multinational study. Adv Exp Med Biol. 2017;971:81–92.
    1. Coraca-Huber DC, Fille M, Hausdorfer J, et al. Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro. J Orthop Res. 2014;32:175–177.
    1. Cunha MT, Murça MA, Nigro S, et al. In vitro antibacterial activity of bioactive glass S53P4 on multiresistant pathogens causing osteomyelitis and prosthetic joint infection. BMC Infect Dis. 2018;18:157.
    1. Lindfors NC, Hyvönen P, Nyyssönen M, et al. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis. Bone. 2010;47:212–218.
    1. Geurts J, Vranken T, Gabriels F, et al. Contemporary treatment of chronic osteomyelitis: implementation in low- and middle-income countries. South Afr Orhopaedic J. 2018;17:40–43.
    1. Metsemakers WJ, Moriarty TF, Nijs S, et al. Influence of implant properties and local delivery systems on the outcome in operative fracture care. Injury. 2016;47:595–604.
    1. Fuchs T, Stange R, Schmidmaier G, et al. The use of gentamicin-coated nails in the tibia: preliminary results of a prospective study. Arch Orthop Trauma Surg. 2011;131:1419–1425.
    1. Metsemakers WJ, Reul M, Nijs S. The use of gentamicin-coated nails in complex open tibia fracture and revision cases: a retrospective analysis of a single centre case series and review of the literature. Injury. 2015;46:2433–2437.
    1. Ruszczak Z, Friess W. Collagen as a carrier for on-site delivery of antibacterial drugs. Adv Drug Deliv Rev. 2003;55:1679–1698.
    1. Wernet E, Ekkernkamp A, Jellestad H, et al. Antibiotic-containing collagen sponge in therapy of osteitis [in German]. Unfallchirurg. 1992;95:259–264.
    1. Chaudhary S, Sen RK, Saini UC, et al. Use of gentamicin-loaded collagen sponge in internal fixation of open fractures. Chin J Traumatol. 2011;14:209–214.
    1. Knaepler H. Local application of gentamicin-containing collagen implant in the prophylaxis and treatment of surgical site infection in orthopaedic surgery. Int J Surg. 2012;10(suppl 1):S15–S20.
    1. Bennett-Guerrero E, Ferguson TB, Jr, Lin M, et al. Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trial. JAMA. 2010;304:755–762.
    1. Stemberger A, Grimm H, Bader F, et al. Local treatment of bone and soft tissue infections with the collagen-gentamicin sponge. Eur J Surg Suppl. 1997;578:17–26.
    1. Walz M. Use of a collagen-gentamicin compound in open spongiosaplasty in chronic post-traumatic osteomyelitis [in German]. Aktuelle Probl Chir Orthop. 1990;34:104–106.
    1. ter Boo GJ, Grijpma DW, Moriarty TF, et al. Antimicrobial delivery systems for local infection prophylaxis in orthopedic- and trauma surgery. Biomaterials. 2015;52:113–125.
    1. Giavaresi G, Meani E, Sartori M, et al. Efficacy of antibacterial-loaded coating in an in vivo model of acutely highly contaminated implant. Int Orthop. 2014;38:1505–1512.
    1. Boot W, Gawlitta D, Nikkels PGJ, et al. Hyaluronic acid-based hydrogel coating does not affect bone apposition at the implant surface in a rabbit model. Clin Orthop Relat Res. 2017;475:1911–1919.
    1. Malizos K, Blauth M, Danita A, et al. Fast-resorbable antibiotic-loaded hydrogel coating to reduce post-surgical infection after internal osteosynthesis: a multicenter randomized controlled trial. J Orthop Traumatol. 2017;18:159–169.
    1. Moriarty TF, Kuehl R, Coenye T, et al. Orthopaedic device-related infection: current and future interventions for improved prevention and treatment. EFORT Open Rev. 2016;1:89–99.
    1. Alexander JW. History of the medical use of silver. Surg Infect (Larchmt). 2009;10:289–292.
    1. Fromm KM. Bioinorganic chemistry of silver: its interactions with amino acids and peptides. Chim (Aarau). 2013;67:851–854.
    1. Brennan SA, Ní Fhoghlú C, Devitt BM, et al. Silver nanoparticles and their orthopaedic applications. Bone Joint J. 2015;97-B:582–589.
    1. Maillard JY, Hartemann P. Silver as an antimicrobial: facts and gaps in knowledge. Crit Rev Microbiol. 2013;39:373–383.
    1. Siegel HJ, Herrera DF, Gay J. Silver negative pressure dressing with vacuum-assisted closure of massive pelvic and extremity wounds. Clin Orthop Relat Res. 2014;472:830–835.
    1. Rupp ME, Lisco SJ, Lipsett PA, et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med. 2005;143:570–580.
    1. Saint S, Elmore JG, Sullivan SD, et al. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med. 1998;105:236–241.
    1. Kollef MH, Afessa B, Anzueto A, et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA. 2008;300:805–813.
    1. Glehr M, Leithner A, Friesenbichler J, et al. Argyria following the use of silver-coated megaprostheses: no association between the development of local argyria and elevated silver levels. Bone Joint J. 2013;95-B:988–992.
    1. Schmolders J, Koob S, Schepers P, et al. Lower limb reconstruction in tumor patients using modular silver-coated megaprostheses with regard to perimegaprosthetic joint infection: a case series, including 100 patients and review of the literature. Arch Orthop Trauma Surg. 2017;137:149–153.
    1. Massè A, Bruno A, Bosetti M, et al. Prevention of pin track infection in external fixation with silver coated pins: clinical and microbiological results. J Biomed Mater Res. 2000;53:600–604.
    1. Kutateladze M, Adamia R. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol. 2010;28:591–595.
    1. Akanda ZZ, Taha M, Abdelbary H. Current review-The rise of bacteriophage as a unique therapeutic platform in treating peri-prosthetic joint infections. J Orthop Res. 2018;36:1051–1060.
    1. Alisky J, Iczkowski K, Rapoport A, et al. Bacteriophages show promise as antimicrobial agents. J Infect. 1998;36:5–15.
    1. Morozova VV, Vlassov VV, Tikunova NV. Applications of bacteriophages in the treatment of localized infections in humans. Front Microbiol. 2018;9:1696.
    1. Yilmaz C, Colak M, Yilmaz BC, et al. Bacteriophage therapy in implant-related infections: an experimental study. J Bone Joint Surg Am. 2013;95:117–125.
    1. Ferry T, Leboucher G, Fevre C, et al. Salvage debridement, antibiotics and implant retention (“DAIR”) with local injection of a selected cocktail of bacteriophages: is it an option for an elderly patient with relapsing Staphylococcus aureus prosthetic-joint infection? Open Forum Infect Dis. 2018;5:ofy269.
    1. Vandenheuvel D, Lavigne R, Brüssow H. Bacteriophage therapy: advances in formulation strategies and human clinical trials. Annu Rev Virol. 2015;2:599–618.
    1. Malik DJ, Sokolov IJ, Vinner GK, et al. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Adv Colloid Interf Sci. 2017;249:100–133.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit